Showing results (61-70 of 245) with videos related to
Sort By:
Pageof 25
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 14, 2019
Radiofrequency ablation for hepatocellular carcinoma: Clinical value of ultrasound-ultrasound overlay fusion for optimal ablation and local controllabilityYasunori Minami, Tomohiro Minami, Masahiro Takita, et al.Journal of Medical Virology|June 15, 2019
Switching from entecavir to tenofovir alafenamide versus maintaining entecavir for chronic hepatitis BSatoru Hagiwara, Naoshi Nishida, Hiroshi Ida, et al.Cancers|October 14, 2022
Prognostic Factors for Overall Survival in Patients with HCV-Related HCC Undergoing Molecular Targeted Therapies: Beyond a Sustained Virological ResponseYasunori Minami, Tomoko Aoki, Hirokazu Chishina, et al.Internal Medicine (Tokyo, Japan)|December 1, 2024
Peliosis Hepatis Complicated by Scleroderma and Rapidly Progressing to Liver FailureSatoru Hagiwara, Hiroshi Ida, Takaaki Chikugo, et al.Journal of Hepato-Biliary-Pancreatic Surgery|October 3, 2006
Genome-wide microsatellite analysis of focal nodular hyperplasia: a strong tool for the differential diagnosis of non-neoplastic liver nodule from hepatocellular carcinomaShunji Nakayama, Yoshihiro Kanbara, Takafumi Nishimura, et al.Digestive Diseases (Basel, Switzerland)|November 28, 2013
Clinical and histological features of different types of Budd-Chiari syndrome: a comparison of 4 casesNaoshi Nishida, Shinichi Iwamura, Hiroshi Ida, et al.Clinical Journal of Gastroenterology|March 4, 2024
Hereditary hemorrhagic telangiectasia with hepatic arteriovenous shunt diagnosed due to liver damageSatoru Hagiwara, Toru Takase, Itsuki Oda, et al.Scientific Reports|January 5, 2025
Observational pilot study of switching from entecavir to tenofovir alafenamide in patients with chronic hepatitis BTakuya Matsubara, Satoru Hagiwara, Naoshi Nishida, et al.Cancer Science|January 23, 2015
Cold-inducible RNA-binding protein promotes the development of liver cancerToshiharu Sakurai, Norihisa Yada, Tomohiro Watanabe, et al.Cancer Reports (Hoboken, N.J.)|January 10, 2024
Hemophagocytic lymphohistiocytosis induced by nivolumab/ipilimumab combination therapy: A case of lung adenocarcinoma that responded to early steroid pulse therapySatoru Hagiwara, Junko Tanizaki, Hidetoshi Hayashi, et al.Pageof 25